Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 20.27% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFIX
851
Stitch Fix
SFIX
$474M
| $14M | 0.02% |
+349,245
| New | +$16.3M |
|
852
TriCo Bancshares
TCBK
$1.84B
| $13.9M | 0.02% |
320,042
-23,772
| -7% | -$963K |
|
853
Globus Medical
GMED
$11.5B
| $13.8M | 0.02% |
180,646
+37,546
| +26% | +$3.01M |
|
|
CMRX
854
DELISTED
Chimerix, Inc.
CMRX
| $13.8M | 0.02% |
2,232,882
-266,767
| -11% | -$1.83M |
|
|
MCFE
855
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $13.8M | 0.02% |
625,000
+327,900
| +110% | +$8.48M |
|
|
TIGR
856
UP Fintech Holding
TIGR
$818M
| $13.8M | 0.02% |
1,301,673
+98,275
| +8% | +$1.54M |
|
857
Dentsply Sirona
XRAY
$2.27B
| $13.8M | 0.02% |
237,358
-795,600
| -77% | -$49M |
|
858
Centrus Energy
LEU
$3.69B
| $13.7M | 0.02% |
355,135
-15,000
| -4% | -$416K |
|
859
Ducommun
DCO
$3.04B
| $13.7M | 0.02% |
272,200
-21,600
| -7% | -$1.13M |
|
860
Grupo Aeroportuario Centro Norte
OMAB
$5.28B
| $13.7M | 0.02% |
292,313
-46,818
| -14% | -$2.27M |
|
861
Phibro Animal Health
PAHC
$1.37B
| $13.7M | 0.02% |
635,300
-29,900
| -4% | -$720K |
|
862
Star Group
SGU
$417M
| $13.6M | 0.02% |
1,333,845
-80,000
| -6% | -$867K |
|
863
Lamar Advertising Co
LAMR
$15.6B
| $13.5M | 0.02% |
119,412
+105,300
| +746% | +$11.5M |
|
864
STMicroelectronics
STM
$48.1B
| $13.5M | 0.02% |
310,324
-958,957
| -76% | -$40.4M |
|
865
10x Genomics
TXG
$7.52B
| $13.5M | 0.02% |
+92,416
| New | +$15.9M |
|
|
CELL
866
DELISTED
PhenomeX Inc. Common Stock
CELL
| $13.4M | 0.02% |
+686,980
| New | +$26.1M |
|
|
TEN
867
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $13.4M | 0.02% |
940,600
-665,300
| -41% | -$10.7M |
|
868
EPR Properties
EPR
$4.7B
| $13.4M | 0.02% |
271,111
+141,511
| +109% | +$7.18M |
|
869
SiriusXM
SIRI
$9.43B
| $13.3M | 0.02% |
+218,690
| New | +$13.7M |
|
870
Global Industrial
GIC
$1.49B
| $13.3M | 0.02% |
350,674
-10,600
| -3% | -$398K |
|
871
Full House Resorts
FLL
$83.5M
| $13.2M | 0.02% |
1,243,490
+18,200
| +1% | +$155K |
|
872
Federal Realty Investment Trust
FRT
$10.2B
| $13.2M | 0.02% |
+111,800
| New | +$13.3M |
|
873
Rush Enterprises Class A
RUSHA
$9.41B
| $13.2M | 0.02% |
437,615
-101,400
| -19% | -$3M |
|
874
White Mountains Insurance
WTM
$5.06B
| $13.2M | 0.02% |
12,300
-3,000
| -20% | -$3.35M |
|
875
DHI Group
DHX
$166M
| $13.1M | 0.02% |
2,758,510
-296,648
| -10% | -$1.16M |
|
Similar funds
Jim Simons's Q3 2021 Portfolio in Review
As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
- Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
- Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
- Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Jim Simons opened 663 new positions and closed 653 in Q3 2021.
- Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.